Physician profile
Antonio Roman
NPI 1396774675
$911.64
in general payments reported to CMS, 2019-2025
11 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.23 · 2020: $40.60 · 2021: $38.14 · 2022: $286 · 2023: $23.13 · 2024: $246 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $287.45 | 2022-2025 | Watchman Flx |
| Medtronic, INC. | $180.13 | 2022-2025 | Cobalt Dr Mri Surescan |
| Genzyme Corporation | $124.97 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $120.76 | 2024 | Airsupra |
| Biotronik INC. | $49.23 | 2019 | |
| Pfizer INC. | $39.08 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $24.88 | 2025 | |
| Lantheus Medical Imaging, INC. | $24.11 | 2020 | |
| Bracco Diagnostics INC. | $23.13 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $21.41 | 2021 | |
| Cook Medical LLC | $16.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.